86-MM0291.00-0250 - carvedilol | 72956-09-3
Sorry, no product with reference 86-MM0291.00-0250 been found, but please check out the following similar products:
Carvedilol
CAS:Formula:C24H26N2O4Purity:>98.0%(T)(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:406.48Carvedilol
CAS:CarvedilolFormula:C24H26N2O4Purity:99.8%Color and Shape:WhiteMolecular weight:406.18926Carvedilol
CAS:Cardiovascular drugs, nesoiFormula:C24H26N2O4Color and Shape:White Off-White Crystalline PowderMolecular weight:406.18926Carvedilol
CAS:Formula:C24H26N2O4Purity:≥ 98.0% (dried basis)Color and Shape:White or almost white crystalline powderMolecular weight:406.47Carvedilol
CAS:Carvedilol (SKF 105517) Phosphate is the phosphate salt form of carvedilol, a racemic mixture and adrenergic blocking agent with antihypertensive activity and devoid of intrinsic sympathomimetic activity. The S enantiomer of carvedilol nonselectively binds to and blocks beta-adrenergic receptors, thereby exerting negative inotropic and chronotropic effects, and leading to a reduction in cardiac output. In addition, both enantiomers of carvedilol bind to and block alpha 1-adrenergic receptors, thereby causing vasodilation and reducing peripheral vascular resistance.Formula:C24H26N2O4Purity:99.73% - 99.97%Color and Shape:Colourless Crystalline PowderMolecular weight:406.47Carvedilol
CAS:Controlled ProductApplications Carvedilol is a nonselective β-adrenergic blocker with α1-blocking activity. Carvedilol is an antihypertensive used in the treatment of congestive heart failure.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Hirohashi, M., et al.: Arzneim.-Forsch., 40, 735 (1990); Packer, M., et al.: N. Engl. J. Med., 334, 1349 (1996);Formula:C24H26N2O4Color and Shape:WhiteMolecular weight:406.47Carvedilol
CAS:Controlled ProductCarvediol is a nonselective beta-adrenoceptor blocking agent and an alpha 1-adrenoceptor blocker. It can be used as a drug, belonging to the class of beta blockers, in the treatment of heart failure, coronary artery disease, and hypertension. Carvedilol has been shown to reduce the risk of death in patients with heart failure and improve symptoms. Furthermore it has an effect on blood pressure by decreasing peripheral vascular resistance and mean arterial pressure. Carvedilol can be metabolized by cytochrome P450 enzymes and CYP2D6 and CYP2C9 liver enzymes.Formula:C24H26N2O4Purity:Min. 98.5 Area-%Color and Shape:White Off-White PowderMolecular weight:406.47 g/molCARVEDILOL FOR SYSTEM SUITABILITY CRS
CAS:CARVEDILOL FOR SYSTEM SUITABILITY CRSFormula:C24H26N2O4Color and Shape:Added ModifiedMolecular weight:406.4742CARVEDILOL CRS
CAS:CARVEDILOL CRSFormula:C24H26N2O4Color and Shape:Added ModifiedMolecular weight:406.4742
